Healthcare & Life Sciences
Pharmasset
United States
acquired
acquired
Stage
About
Pharmasset developed the first oral therapeutic for the treatment of hepatitis C virus (HCV) and human immunodeficiency virus (HIV).
Explore Pharmasset's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.